Belani, C P <br/><br/>
Paclitaxel and carboplatin with and without filgrastim support in patients with metastatic non-small cell lung cancer.  [electronic resource] 

 -  Seminars in oncology  Aug 1995 
 - 7-12 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article 
<br/><br/><label>ISSN: </label>0093-7754 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Carboplatin--administration & dosage<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Clinical Trials, Phase II as Topic<br/>Cohort Studies<br/>Creatinine--urine<br/>Dose-Response Relationship, Drug<br/>Drug Tolerance<br/>Filgrastim<br/>Glomerular Filtration Rate<br/>Granulocyte Colony-Stimulating Factor--therapeutic use<br/>Humans<br/>Infusions, Intravenous<br/>Lung Neoplasms--drug therapy<br/>Neutropenia--chemically induced<br/>Paclitaxel--administration & dosage<br/>Recombinant Proteins--therapeutic use<br/>Remission Induction<br/>Thrombocytopenia--chemically induced